Laser-induced mottled hypopigmentation successfully treated with a combined regimen of topical calcineurin inhibitors and fractional CO2 laser

Se‐Hoon Lee(Samsung Medical Center), Hei Sung Kim(Chonnam National University Hospital), Jeong Deuk Lee(The Catholic University of Korea Incheon St. Mary's Hospital), Minah Cho(Yonsei University), Yu Han(Incheon St. Mary's Hospital), Yu Ri Woo(The Catholic University of Korea Incheon St. Mary's Hospital), Sang Hyun Cho(The Catholic University of Korea Incheon St. Mary's Hospital)
Dermatologica Sinica
January 1, 2022
10.4103/ds.ds_2_22
Cited by 1

Related Papers

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
|Journal of Clinical Oncology|2016|859
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2024|233
Microbiome of the Skin and Gut in Atopic Dermatitis (AD): Understanding the Pathophysiology and Finding Novel Management Strategies
|Journal of Clinical Medicine|2019|228